FASpecT/CT:一种在放射性碘治疗甲状腺癌显像中具有更高灵敏度和效率的新型SPECT/CT采集协议
该研究回顾性分析了30例接受放射性碘治疗的分化型甲状腺癌(DTC)患者的FASpecT/CT图像,该协议采用12个采样视角(常规SPECT为60-64个),通过迭代重建实现。FASpecT/CT被判定可提高低计数率患者的病灶检出率,并在高计数率患者中缩短采集时间。作者认为该采集协议在放射性碘治疗的DTC中有望提高低计数率下转移性淋巴结检测的灵敏度,并在高计数率下显著减少成像时间。
要点
- FASpecT/CT采用12个采样视角,常规SPECT为60-64个,通过迭代重建实现。
- FASpecT/CT被判定可提高低计数率患者的病灶检出率。
- 在高计数率患者中,FASpecT/CT缩短了采集时间。
核心结论
- 作者认为,FASpecT/CT在放射性碘治疗的DTC中有望提高低计数率下转移性淋巴结检测的灵敏度,并在高计数率下显著减少成像时间,使SPECT/CT更易被难以耐受长时间成像的患者(包括儿童人群)接受。
研究设计与样本
- 回顾性分析2017年7月至2019年3月在University Hospital, San Antonio, Tex接受放射性碘治疗的30例DTC患者的FASpecT/CT图像,该协议采用12个采样视角,常规SPECT为60-64个,通过迭代重建实现。
主要发现
- FASpecT/CT协议被判定可提高低计数率患者的病灶检出率。
- 在高计数率患者中,该技术缩短了采集时间。
- 30例患者中展示了4例的FASpecT/CT患者图像作为病例示例。
关键数值与推荐
- FASpecT/CT采用12个采样视角,常规SPECT为60-64个采样视角。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This article demonstrates the use of a new SPECT/CT acquisition protocol in patients with differentiated thyroid cancer (DTC). METHODS: SPECT/CT scans (FASpecT/CT) with fewer angle acquisitions were retrospectively reviewed in 30 DTC patients treated with radioiodine at University Hospital, San Antonio, Tex, from July 2017 to March 2019. This FASpecT/CT of 12 versus 60 to 64 sampled views for convention SPECT was made possible by iterative reconstruction. RESULTS: The FASpecT/CT protocol was judged to increase lesion detection in patients with low count rates. Furthermore, in patients with higher count rates, this technique reduced the acquisition time. FASpecT/CT patient images are shown as case examples in 4 of the 30 patients reviewed. CONCLUSIONS: This FASpecT/CT acquisition in radioiodine-treated DTC offers the potential of higher sensitivity for metastatic lymph node detection in low count rates and a significant decrease in imaging time in high count rates. These advantages make SPECT/CT imaging more acceptable for patients who have difficulty with longer imaging times, to include the pediatric population.
引用
- Phillips WT, Kukkar V, Francis GL, et al. FASpecT/CT, A New SPECT/CT Acquisition With Higher Sensitivity and Efficiency in Radioiodine Thyroid Cancer Imaging. Clin Nucl Med. 2020. PMID: 32149813. doi:10.1097/RLU.0000000000002978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。